The present study evaluated the response of newly diagnosed NAFLD patients with or without obesity to the metformin effect in the context of the monocyte TLR4 level and production of pro-inflammatory cytokines. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.